BAYER A.G. (BAYZF)
Clinical trial NCT05348733 updates: 1. completion date: 2026-12-15 → 2027-12-15 2. primary completion date: 2026-09-30 → 2027-09-01
Clinical trial NCT05348733 updates: 1. completion date: 2026-12-15 → 2027-12-15 2. primary completion date: 2026-09-30 → 2027-09-01
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical